Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.
PURPOSE: Discordance between HER2 expression in tumor tissue (tHER2) and HER2 status on circulating tumor cells (cHER2) has been reported. It remains largely underexplored whether patients with tHER2
METHODS: cHER2 status was determined in 105 advanced-stage patients with tHER2
RESULTS: Compared to the patients with low-risk cHER2 (cHER2
CONCLUSION: In advanced-stage breast cancer patients with tHER2
Breast cancer research and treatment
Wang, C., Mu, Z., Ye, Z., Zhang, Z., Abu-Khalaf, M., Silver, D., Palazzo, J., Jagannathan, G., Fellin, F., Bhattacharya, S., Jaslow, R., Tsangaris, T., Berger, A., Neupane, M., Cescon, T., Lopez, A., Yao, K., Chong, W., Lu, B., Myers, R., Hou, L., Wei, Q., Li, B., Cristofanilli, M., & Yang, H. (2020). Prognostic value of HER2 status on circulating tumor cells in advanced-stage breast cancer patients with HER2-negative tumors.. Breast cancer research and treatment, 181 (3), 679-689. https://doi.org/https://doi.org/10.1007/s10549-020-05662-x